AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,462 | +13.9% | 164 | +17.1% | 0.00% | 0.0% |
| Q2 2023 | $10,061 | +20.8% | 140 | +3.7% | 0.00% | 0.0% |
| Q1 2023 | $8,327 | -20.0% | 135 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $10,413 | +73.6% | 135 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | +20.0% | 135 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $5,000 | +66.7% | 135 | +107.7% | 0.00% | – |
| Q1 2022 | $3,000 | -62.5% | 65 | -68.6% | 0.00% | -100.0% |
| Q4 2021 | $8,000 | +14.3% | 207 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | 0.0% | 200 | +85.2% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | +16.7% | 108 | -2.7% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | -25.0% | 111 | +11.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | +14.3% | 100 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |